In addition, we further analyzed AQP4-related immunotherapy targets through the TTD database and found that in the GBM classification, the therapeutic targets significantly associated with AQP4 expression were EGFR, ABAT, and PDGFRA. The gene discussed is ABAT; the disease is glioblastoma.